Concept Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 16.00 Cr
as on 23-10-2024
- Paid Up Capital ₹ 12.00 Cr
as on 23-10-2024
- Company Age 45 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 218.83 Cr
as on 23-10-2024
- Satisfied Charges ₹ 77.95 Cr
as on 23-10-2024
- Revenue -19.71%
(FY 2023)
- Profit -57.82%
(FY 2023)
- Ebitda -28.34%
(FY 2023)
- Net Worth 1.49%
(FY 2023)
- Total Assets 1.34%
(FY 2023)
About Concept Pharmaceuticals
The Corporate was formerly known as Concept Pharmaceuticals Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 16.00 Cr and a paid-up capital of Rs 12.00 Cr.
The company currently has active open charges totaling ₹218.83 Cr. The company has closed loans amounting to ₹77.95 Cr, as per Ministry of Corporate Affairs (MCA) records.
Adhyatma Gupta, Yugin Gupta, and Ved Kumar serve as directors at the Company.
- CIN/LLPIN
U24239MH1979PLC021126
- Company No.
021126
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
20 Mar 1979
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Concept Pharmaceuticals Limited offer?
Concept Pharmaceuticals Limited offers a wide range of products and services, including Anti Infective Drugs & Medicines, Antibacterial Drugs, Pain Relief Drugs & Pharmaceuticals, Pain Killers, Antibiotic Tablets, Capsule & Syrup, Pharmaceutical Medicine, Arthritic Drugs, Dexamethasone Injection, Antibiotic Tablets & Capsules, Cefixime Tablet.
Who are the key members and board of directors at Concept Pharmaceuticals?
Executive Team (1)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Adhyatma Gupta | Managing Director | 27-Dec-1984 | Current |
Board Members(2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Yugin Gupta | Director | 01-Nov-2012 | Current |
Ved Kumar | Director | 29-Sep-1995 | Current |
Financial Performance and Corporate Structure Insights of Concept Pharmaceuticals.
Concept Pharmaceuticals Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 19.71% decrease. The company also saw a substantial fall in profitability, with a 57.82% decrease in profit. The company's net worth moved up by a moderate rise of 1.49%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Concept Pharmaceuticals?
In 2023, Concept Pharmaceuticals had a promoter holding of 0.03% and a public holding of 99.97%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
Lender | Amount | Status |
---|---|---|
The Hongkong And Shanghai Banking Corporation Limited Creation Date: 27 Sep 2022 | ₹3.00 Cr | Open |
Others Creation Date: 18 Nov 2021 | ₹3.73 Cr | Open |
Canara Bank Creation Date: 12 Mar 2021 | ₹43.00 Cr | Open |
How Many Employees Work at Concept Pharmaceuticals?
Concept Pharmaceuticals has a workforce of 537 employees as of Aug 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Concept Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Concept Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.